At Lucent Diagnostics, we are proud to unveil our breakthrough product, LucentAD. Designed to transform the landscape of Alzheimer’s disease diagnostic testing, LucentAD uses cutting-edge technology to provide accurate and actionable results from a blood sample and empower healthcare professionals while improving patient outcomes.
With LucentAD, Lucent Diagnostics aims to address the critical need for advanced diagnostic tools that can measure biomarkers associated with neurodegenerative diseases, such as phosphorylated Tau (p-Tau). Our innovative solution provides clinicians with the information they need in conjunction with other diagnostic tools, to make informed decisions and optimize patient care.
Alzheimer’s Pathology Detection Made Simple
The recent emergence of promising new Alzheimer’s therapies has brought to light an urgent need for improved tools to help diagnose the disease in its early stages when therapeutic intervention is most likely to deliver clinical benefit.
View details on our CLIA-validated laboratory-developed test, LucentAD, for the quantitative determination of p-Tau in EDTA plasma.
Check back soon for Test Specifications.
Join Us Today
Join us on this transformative journey. Discover how LucentAD, powered by Quanterix, can empower you with the knowledge and confidence to navigate the complexities of Alzheimer’s disease. Take control of your health and unlock a brighter future today.
Contact Us to Order a Test
The information provided on this website is for educational purposes only and should not be considered as medical advice. Please consult with your healthcare provider for personalized guidance and treatment options.